Amlexanox oral adhesive pellicles treats MiRAU.
Completed
- Conditions
- HEALTH
- Registration Number
- NL-OMON22280
- Lead Sponsor
- Beijing Fu Rei Kang Zheng Medical and Pharmaceutical Institute
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 216
Inclusion Criteria
1. Males and females aged 18-60 years old;
2. Willingness to participate and sign the informed consent forms;
Exclusion Criteria
1. A known history of serious drug hypersensitivities;
2. Pregnancy and lactation (Urine hCG-positive);
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amlexanox oral adhesive pellicles significantly reduced ulcer size and alleviated ulcer pain.
- Secondary Outcome Measures
Name Time Method Erythema exudation.